Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: monoclonal antibody drugs

4/3/2017

Lack of independent sources weaken NBC’s look at pricey eczema drug

11/21/2016

Bloomberg’s conflicted sources ‘love’ new cholesterol drugs — readers need to know about financial relationships with pharma

10/20/2016

Potential conflicts of interest abound in HealthDay’s look at Lemtrada for early stages of MS

5/24/2016

Except for presidential anecdote, NBC story on new melanoma drug was well-balanced